Company intelligence
Agenus
About Agenus
Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA. For more information, visit www.agenusbio.com or follow us at @agenus_bio. Our Community Guidelines are available at our website and at: https://agenusbio.com/community-guidelines/
Verified activity
Signals from Agenus
2 published signals
Research & Knowledge
Agenus published a new research manuscript detailing how Bot-BAL may reshape the tumor microenvironment in metastatic colorectal cancer.
Reported by Agenus
Presence & Recognition
Agenus will participate in two upcoming investor conferences this September, including fireside chats and 1:1 investor meetings at the Cantor Fitzgerald Global Healthcare Conference and H.C. Wainwright & Co., LLC 28th Annual Global Investment Conference.
Reported by Agenus